Erol Akpınar
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection 3
- Apelin-related biomedical research 3
- Rehabilitation top 10%
-
- Eicosanoids and Hypertension Pharmacology 4
-
- Nitric Oxide and Endothelin Effects 5
-
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 4
-
- Neuropeptides and Animal Physiology 4
-
- Acute Kidney Injury Research 3
-
- Vitamin C and Antioxidants Research 3
- Co-authors
- Zekai HalıcıElif ÇadırcıYasin BayırMuhammed YaylaHarun ÜnRüstem Anıl UğanEmre KarakuşZafer Bayraktutan
- Partner nations
- TürkiyeUnited StatesGreece
In The Last Decade
Erol Akpınar
33 papers receiving 487 citations
Peers
Comparison fields: 5 of 89
- Pharmacology 55
- Drug Discovery 1
- Rehabilitation 36
- Critical Care and Intensive Care Medicine 27
- Biochemistry 33
Countries citing papers authored by Erol Akpınar
This map shows the geographic impact of Erol Akpınar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erol Akpınar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erol Akpınar more than expected).
Fields of papers citing papers by Erol Akpınar
This network shows the impact of papers produced by Erol Akpınar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erol Akpınar. The network helps show where Erol Akpınar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erol Akpınar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 5 | |
| 6 | 2021 | 15 | |
| 7 | 2019 | 38 | |
| 8 | 2018 | 35 | |
| 9 | 2015 | 23 | |
| 10 | 2015 | 15 | |
| 11 | 2015 | 9 | |
| 12 | 2015 | 12 | |
| 13 | 2014 | 5 | |
| 14 | 2014 | 0 | |
| 15 | 2014 | 27 | |
| 16 | 2014 | 21 | |
| 17 | 2014 | 13 | |
| 18 | 2014 | 12 | |
| 19 | 2014 | 41 | |
| 20 | 1995 | 1 |
About Erol Akpınar
Erol Akpınar is a scholar working on Biochemistry, Pharmacology and Complementary and Manual Therapy, having authored 34 papers that have together received 498 indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (5 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Neuropeptides and Animal Physiology (4 papers), Acute Kidney Injury Research (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Apelin-related biomedical research (3 papers) and Vitamin C and Antioxidants Research (3 papers). The work is most often cited by research in Pharmacology (55 citations), Drug Discovery (1 citation) and Rehabilitation (36 citations). Erol Akpınar has collaborated with scholars based in Türkiye, United States and Greece. Frequent co-authors include Zekai Halıcı, Elif Çadırcı, Yasin Bayır, Muhammed Yayla, Harun Ün, Rüstem Anıl Uğan, Emre Karakuş, Zafer Bayraktutan, Hasan Atmaca and İrfan Çınar.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.